Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Other Non Operating Income: 2023-2025

Historic Other Non Operating Income for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $1.1 million.

  • Zenas BioPharma's Other Non Operating Income fell 54.54% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 100.02%. This contributed to the annual value of $8.2 million for FY2024, which is 1210.10% up from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Other Non Operating Income is $1.1 million, which was down 63.48% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Other Non Operating Income ranged from a high of $3.6 million in Q1 2025 and a low of -$16,000 during Q3 2023.
  • Its 3-year average for Other Non Operating Income is $1.8 million, with a median of $1.9 million in 2024.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first spiked by 14,962.50% in 2024, then crashed by 54.54% in 2025.
  • Over the past 3 years, Zenas BioPharma's Other Non Operating Income (Quarterly) stood at $793,000 in 2023, then spiked by 334.80% to $3.4 million in 2024, then plummeted by 54.54% to $1.1 million in 2025.
  • Its Other Non Operating Income stands at $1.1 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.6 million for Q1 2025.